tiprankstipranks
Trending News
More News >
Vivos Therapeutics (VVOS)
NASDAQ:VVOS
US Market

Vivos Therapeutics (VVOS) Income Statement

Compare
206 Followers

Vivos Therapeutics Income Statement

Last quarter (Q1 2025), Vivos Therapeutics's total revenue was $3.02M, a decrease of -11.79% from the same quarter last year. In Q1, Vivos Therapeutics's net income was $-3.86M. See Vivos Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 15.03M$ 13.80M$ 16.02M$ 16.89M$ 13.07M
Gross Profit
$ 9.02M$ 8.27M$ 10.02M$ 12.60M$ 10.41M
Operating Expenses
$ 20.19M$ 25.57M$ 35.05M$ 32.08M$ 19.12M
Depreciation and Amortization
$ 581.00K$ 621.00K$ 669.00K$ 733.00K$ 717.87K
EBITDA
$ -10.55M$ -16.68M$ -24.36M$ -19.54M$ -11.24M
Operating Income
$ -11.17M$ -17.30M$ -25.03M$ -19.47M$ -8.71M
Other Income/Expenses
$ 35.00K$ 3.71M$ 1.19M$ 94.00K$ -16.88K
Pretax Income
$ -11.14M$ -13.58M$ -23.84M$ -20.29M$ -12.06M
Net Income
$ -11.14M$ -13.58M$ -22.66M$ -20.29M$ -8.82M
Per Share Metrics
Basic EPS
$ -1.68$ -11.14$ -24.62$ -23.89$ -12.11
Diluted EPS
$ -1.68$ -11.14$ -24.62$ -23.89$ -12.11
Weighted Average Shares Outstanding
5.02M 1.22M 920.48K 849.32K 728.38K
Weighted Average Shares Outstanding (Diluted)
5.02M 1.22M 920.48K 849.32K 728.38K
Currency in USD

Vivos Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis